Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis.

RMD Open · 2023 · PMC10357650 · PMID 37460274

Europe PMC DOI

hedged sentences

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

borderline significancep=0.067so close (0.05 < p ≤ 0.1)

7 In the present study, a lower risk of DM was observed in patients receiving TNF-α inhibitors despite borderline significance (p=0.067).

also in 7,017 other papers

did not reach statistical significanceno p-value reported

27 However, we observed that abatacept and tocilizumab did not reach statistical significance, which may be due to the small number of cases.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.